A cross-sectional study of thyroid dysfunction in patients of chronic kidney disease in Goa medical college
DOI:
https://doi.org/10.18203/2320-6012.ijrms20242614Keywords:
Chronic kidney disease, Thyroid hormoneAbstract
Background: Thyroid hormones are essential for regulating metabolism, development, protein synthesis, and other hormone functions. CKD has been linked to changes in the pituitary-thyroid axis and peripheral thyroid hormone metabolism.
Methods: A cross-sectional study was conducted in 100 subjects from September 2019 to September 2021 in the department of medicine, Goa Medical College, a tertiary care hospital in Goa.
Results: Most of the CKD patients in study population are in the Age group of 41-70 years. 70% were male. 54% patients were diabetic and 46% patients were non diabetic, majority of them 87% patients were hypertensive, majority of them were DM and HTN With 88% and few patients belonged to other diseases. 8% patients with high TSH level, 6% with low TSH level, 86% with normal TSH level. TT4 levels were low in 28% patients and normal in 72% patients, TT3 levels were high in 3% patients, low in 60% and normal in 37% patients. FT4 levels were high in 5% patients and low in 7%, normal in 88% patients. FT3 levels were high in 1% patients, low in 49%, normal in 50% patients. 55% patients belong to euthyroid state and 7% patients belongs to hypothyroid state and 36% patients belong to sick euthyroid state and 2% belongs to subclinical thyrotoxicosis.
Conclusions: Most of the participants in this study were euthyroid. The most common thyroid hormone derangement was low T3 values (non-thyroidal illness). The prevalence of hyperthyroidism in this study was 2% and hypothyroidism 7%.
References
Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001;81(3):1097-142.
Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137-47.
Center for Disease Control Prevention (CDC). Prevalence of chronic kidney disease and associated risk factors- United States, 1999-2004. MMWR Morb Mortal Wkly Rep. 2007;56(8):161-5.
Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ. Chronic kidney disease: common, harmful and treatable- World Kidney Day 2007. Am J Nephrol. 2007;27(1):108-12.
Hamer RA, El Nahas AM. The burden of chronic kidney disease. Br Med J. 2006;56.
Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major non-communicable diseases. Kidney Int. 2011;80(12):1258-70.
Katz AI, Lindheimer MD. Actions of hormones on the kidney. Annu Rev Physiol. 1977;39(1):97-133.
Mohanmedali M, Maddika SR, Vyas A, Iyer V, Cheriyath P. Thyroid disorders and chronic kidney disease. Int J Nephrol. 2014;14:1-6.
Ravani P, Quinn R, Fiocco M, Liu P, Al-Wahsh H, Lam N, et al. Association of age with risk of kidney failure in adults with stage IV chronic kidney disease in Canada. JAMA Network Open. 2020;3(9):e2017150.
Bikbov B, Perico N, Remuzzi G. Disparities in chronic kidney disease prevalence among males and females in 195 countries: analysis of the global burden of disease 2016 study. Nephron. 2018;139:313-8.
Wu B, Bell K, Stanford A, Kern DM, Tunceli O, Vupputuri S, et al. Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns- NHANES 2007-2012. BMJ Open Diabetes Res Care. 2016;4(1):e000154.
Weldegiorgis M, Woodward M. The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis. BMC Nephrol. 2020;21(1):1-9.
Kaggia SNN. Thyroid hormone profiles in patients with chronic kidney disease at Kenyatta National Hospital. 2013.
Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”. Endocr Rev. 1982;3(2):164-217.
Hashimoto H, Igarashi N, Miyawaki T, Sato T. Effects of TNF-α, IL-1β, and IL-6 on type-I iodothyronine 5’-deiodination in rat thyroid cell line, FRTL-5. J Interferon Cytokine Res. 1995;15:367-75.
Chonchol M, Lippi G, Salvagno G, Zoppini G, Muggeo M, Targher G. Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008;3(5):1296-300.
Brough R, Jones C. Iatrogenic iodine as a cause of hypothyroidism in infants with end-stage renal failure. Pediatr Nephrol. 2006;21(3):400-2.
Suzuki S, Shigematsu S, Inaba H, Takei M, Takeda T, Komatsu M. Pituitary resistance to thyroid hormones: pathophysiology and therapeutic options. Endocrine. 2011;40(3):366-71.
Adler SM, Wartofsky L. The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am. 2007;36(3):657-72.
Reinhardt W, Misch C, Jockenhövel F, Wu SY, Chopra I, Philipp T, et al. Triiodothyronine (T3) reflects renal graft function after renal transplantation. Clin Endocrinol. 1997;46(5):563-9.
